Answering Your Questions on Developing a Relative Potency Assay for an Anti-Influenza mAb
Dr. Jeff Patrick answers questions on how BioAgilytix translated a diagnostic virus neutralization method to a quantitative relative potency assay for an anti-viral antibody.
